Medicines in Development for Alzheimer's Disease 2017 Report

America’s biopharmaceutical research companies are investigating or developing 85 medicines to help the more than five million patients in the United States who are living with Alzheimer’s.

5+

MILLION AMERICANS

have Alzheimer's disease.

$259

BILLION

cost of Alzheimer's and other dementias in the U.S. in 2017

15

MILLION AMERICANS

provide unpaid care for people with Alzheimer's and other dementias

SIXTH

LEADING CAUSE

of death in the U.S. is Alzheimer's disease

Related Resources

Continuing the search for new Alzheimer’s therapies

Blog Post

Highlighting medicines in development for Alzheimer’s disease.

A new era in Alzheimer’s innovation

Blog Post

Despite numerous setbacks, America's biopharmaceutical companies are combating Alzheimer's disease, with 92 potential new treatments in development.

Biopharmaceutical industry is essential to development of Alzheimer’s treatments

Blog Post

Finding a better treatment and cure for Alzheimer’s is a top priority for biopharmaceutical companies who are already investing billions in the development of new therapies and working collaboratively with the Alzheimer’s community on basic research.